Adap­ti­m­mune’s debt fi­nanc­ing deal; Tenaya to cut work­ers

Plus, news about Brix­ton Bio­sciences, Mer­ck KGaA, Med­in­cell, Cell­Prothera and GSK:

Adap­ti­m­mune inks up to $125M debt fi­nanc­ing: The biotech gets …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.